The case involves a Hollywood, Florida, racetrack and casino that gave a hospitality services union a list of employees, access to its property and a pledge to remain neutral in the union's labor-organizing bid. In exchange, the union agreed not to strike or picket, and it spent $100,000 to support a state ballot initiative that led to legalizing slot machines.
A groundskeeper opposed to the union took the case to court and won a surprising victory at the 11th Circuit Court of Appeals, which ruled that Mardi Gras Gaming gave the union "things of value" barred under the Labor Management Relations Act of 1947. If the Supreme Court upholds that verdict, labor groups say, it would cut off an increasingly important avenue for union organizing.
Best Dow Dividend Stocks To Watch Right Now: Genomic Health Inc (GHDX)
Genomic Health, Inc. (Genomic Health), incorporated in August 2000, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Its Oncotype DX platform utilizes quantitative genomic analysis known as reverse transcription polymerase chain reaction (RT-PCR), in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. As of February 2012, Oncotype DX was evaluated in invasive breast cancer in 13 clinical studies involving more than 4,000 breast cancer patients worldwide. Genomic Health offers its Oncotype DX tests as a clinical service, where it analyzes the expression levels of genes in tumor tissue samples and provide physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score, for invasive breast cancer and colon cancer and a DCIS Score for DCIS. Its Oncotype DX breast cancer test analyzes the expression levels of 21 genes and Oncotype DX colon cancer test analyzes the expression levels of 12 genes. In March 2012, the Company established a wholly owned subsidiary, InVitae Corporation.
Oncotype DX Platform
The Company�� Oncotype DX platform uses its RT-PCR approach to improve cancer treatment decisions. Its diagnostic approach correlates gene expression to clinical outcomes and provides an individualized analysis of each patient's tumor. The Company has built a diagnostic infrastructure that allows it to move from research into development through to processing actual patient samples in its clinical reference laboratory. The Company offers Oncotype DX tests as clinical laboratory services. Its technology allows the Company to analyze tumor tissue samples in its clinical reference laboratory and provide physicians with genomic information specific to the patient'! s tumor. It analyzes tissues that are handled, processed and stored under routine clinical pathology laboratory practices.
Oncotype DX Breast Cancer Test
To develop its Oncotype DX breast cancer test, the Company evaluated 250 genes in three independent clinical studies, which identified a 21-gene panel whose composite gene expression profile can be represented by a breast cancer Recurrence Score. The Company conducted studies of its Oncotype DX breast cancer test with clinical samples from postmenopausal women with invasive breast cancer who were treated with aromatase inhibitors. In March 2010, the Journal of Clinical Oncology published results from a European study using its test to analyze tumor samples from over 1,200 patients in the ATAC (Arimedix, Tamoxifen, Alone or in Combination) trial, which established the use of aromatase inhibitors for adjuvant treatment of postmenopausal women with hormone receptor-positive breast cancer. The study demonstrated that, along with other standard measures, such as tumor size, its Oncotype DX breast cancer test contributes independently to provide a more complete picture of prognosis for N- and N+ patients treated with aromatase inhibitors.
In December 2011, the Company presented positive results from the ECOG E5194 DCIS clinical validation study at SABCS. The study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS Score can predict the risk of local recurrence, defined as either the development of a new invasive breast cancer or the recurrence of DCIS in the same breast. In December 2011, the Company made Oncotype DX available for patients with ductal carcinoma in situ (DCIS), of the breast, a pre-invasive form of breast cancer. The launch of Oncotype DX for DCIS patients was based on positive results presented from a clinical validation study of Oncotype DX breast cancer test in patients with DCIS, conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative! group su! pported by the National Cancer Institute.
Oncotype DX Colon Cancer Test
The Company developed its gene panel by identifying 761 cancer-related genes through review of existing research literature and computer analysis of genomic databases. The 761 candidate genes were also examined to determine whether they would be useful beyond other key variables including tumor stage, tumor grade, lymph nodes examined and MMR/MSI. It selected a final set of 12 genes, which were then independently evaluated in a validation study of over 1,400 stage II colon cancer patients from the Quick and Simple and Reliable (QUASAR), randomized study of adjuvant chemotherapy in the United Kingdom. This international, multi-center randomized trial examined the recurrence risk and the benefit associated with 5-fluorouracil/leucovorin, or 5FU/LV, adjuvant chemotherapy. Gene expression was quantified by RT-PCR from manually microdissected FPE primary colon cancer tissue, and recurrence-free interval, disease-free survival and overall survival were analyzed. In January 2012, the Company presented positive results of the first clinical decision making study of the Oncotype DX colon cancer test that shows that Recurrence Score result has a significant impact on treatment recommendations for stage II colon cancer patients.
The Company competes with General Electric Company, Hologic, Inc., Novartis AG, Myriad Genetics, Inc., Qiagen N.V., Response Genetics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Roche Holding, Ltd, Siemens AG and Johnson & Johnson.
Advisors' Opinion:- [By Keith Speights]
Genetic testing stands out as one current example of how scientific advances can help reduce medical costs. Genomic Health (NASDAQ: GHDX ) makes genetic diagnostic tests for�breast, colon, and prostate cancer. Half of the patients diagnosed with prostate cancer each year actually have a very low risk of the cancer progressing. However, 90% of these low-risk patients still undergo surgery or radiation -- at a cost of tens of thousands of dollars per patient. Genomic Health's genetic test helps identify which patients really need more extensive treatment and holds the potential to reduce overall costs.
Hot Rising Stocks To Own For 2014: FARO Technologies Inc.(FARO)
FARO Technologies, Inc., together with its subsidiaries, designs, develops, manufactures, markets, and supports software-based three-dimensional measurement and imaging systems for manufacturing, industrial, building construction, and forensic applications. The company?s articulated electromechanical measuring devices include FaroArm, a combination of six or seven-axis, instrumented articulated measurement arm, a computer, and CAM2 software programs; FARO Laser ScanArm, a FaroArm equipped with a combination of a hard probe and non-contact line laser probe to measure products without touching them and offers a seven-axis contact/non-contact measurement device with an integrated laser scanner; and FARO Gage, an accuracy version of the FaroArm product. Its laser-based measuring devices comprise FARO Laser Tracker ION that combines a laser measurement tool, a computer, and CAM2 software programs; FARO Focus3D to measure and collect data points; and FARO 3D Imager AMP, a non-c ontact 3D Imager capable of collecting millions of points to generate infinitely-focused fringe patterns. The company also provides CAM2 Software, a proprietary CAD-based measurement and statistical process control software comprising CAM2 Q, CAM2 Measure X, Soft Check Tool, FARO Gage Software, and FARO Focus3D Software. In addition, it offers extended warranties, as well as support, training, and technology consulting services. The company sells its products through direct sales and distributors. It serves the automobile, aerospace, and heavy equipment markets, as well as law enforcement agencies in the Americas, Europe, Africa, and the Asia Pacific. FARO Technologies, Inc. was founded in 1981 and is headquartered in Lake Mary, Florida.
Advisors' Opinion:- [By Alex Planes]
What: Shares of FARO Technologies (NASDAQ: FARO ) are down over 11% today after the company reported underwhelming earnings for the fiscal first quarter.
Hot Rising Stocks To Own For 2014: McGraw Hill Financial Inc (MHFI)
McGraw Hill Financial, Inc. incorporated on December 29, 1925, is a financial intelligence company. The Company is engaged in credit ratings, benchmarks and analytics for the global capital and commodity markets. The Company�� brands include Standard & Poor's Ratings Services, S&P Capital IQ, S&P Dow Jones Indices, Platts, CRISIL, J.D. Power & Associates, McGraw Hill Construction and Aviation Week. The Company�� credit ratings, indices, price assessments and other capabilities provide clients with the intelligence to manage risk. Standard & Poor�� Ratings Services helps investors and markets participants measure and manage credit risk through credit ratings, research and analytics. S&P Capital IQ is a provider of real-time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities globally. On March 22, 2013, the Company sold McGraw-Hill Education. Effective July 18, 2013, McGraw Hill Financial Inc acquired a remaining undisclosed interest which it did not already own in Tata McGraw-Hill Education Pvt Ltd from Tata charitable trust. In August 2013, McGraw Hill Financial Inc completed the sale of Aviation Week to Penton.
The Company provides a range of capabilities designed to help track performance, generate alpha, identify new trading and investment ideas, and perform risk analysis and mitigation strategies. The Company�� S&P Dow Jones Indices is the provider of financial market indices. Its Platts is a provider of information and a source of benchmark price assessments for the energy, petrochemicals, metals and agriculture markets. J.D. Power & Associates is a global marketing information services company operating in business sectors, including customer satisfaction research, market research, social media research, and performance improvement programs. McGraw Hill Construction connects people, projects, and products across the design and construction industry. AVIATION WEEK is! the multimedia information and services provider to the global aviation, aerospace and defense industries.
Advisors' Opinion:- [By Associated Press]
Crude oil supplies grew by 300,000 barrels, or 0.1 percent, in the week ended April 5, according to the Energy Information Administration, the Energy Department's statistical arm. At 388.9 million barrels, the U.S. oil supply is the highest since July 1990. Analysts had expected a bigger increase of 1.4 million barrels, according to Platts, the energy information arm of McGraw-Hill (NYSE: MHFI ) .
Hot Rising Stocks To Own For 2014: H&E Equipment Services Inc.(HEES)
H&E Equipment Services, Inc. operates as an integrated equipment services company. The company rents, sells, and provides parts and service support for hi-lift or aerial work platform equipment, crane, earthmoving equipment, and industrial lift truck categories. It offers heavy construction and industrial equipment for rent on a daily, weekly, and monthly basis. As of December 31, 2011, the company?s fleet consisted of 17,538 pieces of equipment. It also sells new heavy construction and industrial equipment in various categories. In addition, the company sells used equipment from its rental fleet, as well as inventoried equipment that is acquired through trade-ins from its customers and selective purchases; and new and used parts. Further, it provides maintenance and repair services; and ongoing preventative maintenance services and warranty repairs, as well as offers ancillary equipment support activities, including transportation, hauling, parts shipping, and loss damag e waivers. The company provides its services to industrial and commercial companies, construction contractors, manufacturers, public utilities, municipalities, and maintenance contractors, as well as for other industrial accounts. As of February 28, 2012, it operated a network of 65 full-service facilities, serving approximately 29,800 customers across 22 states in the West Coast, Intermountain, Southwest, Gulf Coast, Southeast, and Mid-Atlantic regions of the United States. The company markets its equipment rental services, and new and used equipment through its sales force. H&E Equipment Services, Inc. was founded in 1961 and is headquartered in Baton Rouge, Louisiana.
Advisors' Opinion:- [By Seth Jayson]
Margins matter. The more H&E Equipment Services (Nasdaq: HEES ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong H&E Equipment Services's competitive position could be.
- [By Peter Graham]
The Q2 2014 earnings report for equipment rental stock United Rentals, Inc (NYSE: URI), a peer or competitor of Essex Rental Corp (NASDAQ: ESSX) and H&E Equipment Services, Inc (NASDAQ: HEES), is scheduled for after the market closes on Wednesday. Aside from the United Rentals earnings report, it should be said that the Essex Rental Corp reported Q4 2013 earnings on May 7th while the estimated release date for the H&E Equipment Services, Inc Q2 2014 earnings report is August 4th. However, United Rentals��shares rose after its last earnings report plus analysts have issued bullish research notes since then.
Hot Rising Stocks To Own For 2014: Alliant Energy Corporation (LNT)
Alliant Energy Corporation operates in electric and gas utility businesses in the United States. The company, through its subsidiary, Interstate Power and Light Company, engages in the generation and distribution of electric energy; and the distribution and transportation of natural gas in Iowa and southern Minnesota. As of December 31, 2009, it supplied electric and gas service to approximately 525,334 and 233,841 retail customers. Alliant Energy Corporation also provides steam services, and various other energy-related products and services to customers in Iowa. The company, through its other subsidiary, Wisconsin Power and Light Company (WPL), involves in the generation and distribution of electric energy; and the distribution and transportation of natural gas primarily in south and central Wisconsin markets. As of December 31, 2009, WPL supplied electric and gas service to 453,573 and 177,968 retail customers. In addition, Alliant Energy Corporation has investments in environmental consulting, and engineering and renewable energy services businesses. It also engages in transportation business, which includes a short-line railway for the provision of freight services between Cedar Rapids and Iowa City in Iowa; barge terminal and hauling services on the Mississippi River; and other transfer and storage services. The company was founded in 1917 and is based in Madison, Wisconsin.
Advisors' Opinion:- [By Eric Volkman]
Alliant Energy (NYSE: LNT ) is staying true to form and pumping out its usual reward for shareholders. The company has announced it will distribute a dividend of $0.47 per share of its common stock on May 15 to shareholders of record as of April 30. This matches the firm's previous distribution, which was dispensed at the end of January. Previous to that, Alliant had paid $0.45 per share.
Hot Rising Stocks To Own For 2014: ITonis Inc (ITNS)
ITonis Inc., incorporated on July 5, 2005, operates as a holding company. The Company focuses to purchase entrepreneurial companies that have established themselves, or are expected to establish themselves in various markets.
The Company invests in small growth entrepreneurial companies. In May 2011, the Company acquired Performance Mortgage Group, Inc., as a wholly owned subsidiary.
Advisors' Opinion:- [By Peter Graham]
What�� the Catch With MyEcheck Inc? According to various disclosures, transactions of $500 and $2k have or will occur to mention MyEcheck Inc in various investment newsletters. The most recent news for MyEcheck Inc is not so recent as it dates from last April and was an announcement that the company would license its proprietary system to other operators for a share of their transaction revenue on the system with the CEO pointing out: ��n addition to our processing revenue, we will have licensing revenue that will exceed our processing revenue in a relatively short period of time." However, a quick look at MyEcheck Inc�� financials reveals revenues of $3k (most recent reported quarter), zero, zero and zero for the past four quarters along with net income of $387k (most recent reported quarter) and net losses of $8k, $35k and $14k. At the end of last June, MyEcheck Inc had no cash to cover $804k in current liabilities. So maybe investor will want to wait for evidence of licensing and processing revenue to materialize.
ITonis Inc (OTCMKTS: ITNS) Recently Announced Its First OrderSmall cap ITonis Inc is an Orange County, California based holding company established in 2005 that's is currently undergoing a company-wide transformation to embark upon an aggressive acquisition plan to purchase high growth entrepreneurial companies that have established themselves, or are expected to establish themselves as leaders in various market niches. On Friday, ITonis Inc fell 9.09% to $0.003 for a market cap of $2.56 million plus ITNS is down 80.3% over the past year and down 50% over the past five years according to Google Finance.
Hot Rising Stocks To Own For 2014: Affymetrix Inc.(AFFX)
Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets primarily in the United States, Europe, Japan. The company provides integrated GeneChip microarray platform, which includes disposable DNA probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. It also offers GeneTitan, an instrument system that runs genotyping and gene expression array plates; and GeneAtlas, an instrument for low-to-medium throughput that provides hybridization and array processing with microwell-based labware, as well as a line of multiplex assays to serve the discovery and the validation markets. In addition, the company provides reagent kits, including ExoSAP-IT fo r a reagent for the clean-up of polymerase chain reaction (PCR) products used in downstream applications, such as DNA sequencing or single-nucleotide polymorphisms analysis; and HotStart-IT reagents that utilize a novel primer binding protein to inhibit primer dimer formation with results in sensitive and consistent amplification for PCR. Its products are used primarily in genotyping and gene expression applications. The company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies; academic research centers, government research laboratories, private foundation laboratories, and clinical reference laboratories in North America and Europe, as well as through life science supply specialists acting as authorized distributors in Latin America, the Middle East, and Asia Pacific regions. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.
Advisors' Opinion:- [By Rich Duprey]
It's in the genes
Elsewhere in the market, however,�Affymetrix (NASDAQ: AFFX ) tumbled more than 13% after preannouncing first-quarter earnings that missed even its own expectations. It blamed "headwinds" in its gene expression business everywhere it does business, though it suffered a particular shortfall in Japan. The Fool's Sean Williams thinks that may indicate more than a one-off performance issue because of the global nature of the miss Affymetrix suffered. - [By Monica Gerson]
Breaking news
Costco Wholesale (NASDAQ: COST) reported a 5% gain in its April same-store sales. Costco's US same-store sales climbed 5%, while international sales rose 2% in April. Analysts were estimating a 3.2% gain in April same store sales. To read the full news, click here. Dish Network (NASDAQ: DISH) reported an 18% drop in its first-quarter profit. Dish's quarterly earnings slipped to $175.9 million, or $0.38 per share, versus $215.6 million, or $0.47 per share, in the year-ago period. To read the full news, click here. Affymetrix (NASDAQ: AFFX) and Leica Biosystems announce the launch of Affymetrix' fully automated RNA in situ hybridization assays ViewRNATM eZ Assays on the Leica BOND RX staining platform. To read the full news, click here. Priceline Group (NASDAQ: PCLN) reported a 36% gain in its first-quarter earnings. Priceline's quarterly profit surged to $331.2 million, or $6.25 per share, versus a year-ago profit of $244.3 million, or $4.76 per share. To read the full news, click here.Posted-In: Morgan Stanley US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
No comments:
Post a Comment